Diastolic Dysfunction 2025
Diastolic Dysfunction in the Pregnant Woman With Preeclampsia
1 other identifier
observational
80
1 country
1
Brief Summary
This is a prospective observational study conducted at the Maternity and Neonatology Center of Tunis to evaluate cardiac diastolic function in women with preeclampsia compared with normotensive pregnant women. A total of 80 pregnant women in the third trimester were enrolled, including 40 with preeclampsia (mostly severe forms) and 40 healthy controls. All participants underwent standardized transthoracic echocardiography to assess left ventricular diastolic function according to the 2016 ASE/EACVI recommendations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedFirst Submitted
Initial submission to the registry
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 24, 2025
CompletedSeptember 24, 2025
September 1, 2025
5 months
September 1, 2025
September 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Left Ventricular Diastolic Dysfunction in Preeclamptic Women
Echocardiographic assessment of diastolic function according to ASE/EACVI 2016 criteria, including parameters E, A, E/A ratio, septal and lateral e' velocities, E/e' ratio, left atrial volume index, and tricuspid regurgitation velocity.
At baseline, during third-trimester pregnancy hospital evaluation.
Study Arms (2)
Preeclampsia Group
Pregnant women in the third trimester diagnosed with preeclampsia (mostly severe forms), aged 18-45 years, without pre-existing cardiovascular disease or other exclusion criteria.
Control Group
Normotensive pregnant women in the third trimester, aged 18-45 years, without cardiovascular disease or other exclusion criteria.
Interventions
This is an observational study. No therapeutic intervention is administered. Participants undergo standard echocardiographic assessment of left ventricular diastolic function during pregnancy.
Eligibility Criteria
Pregnant women in the third trimester recruited at the Center of Maternity and Neonatology of Tunis, including 40 with preeclampsia (mainly severe forms) and 40 normotensive controls.
You may qualify if:
- Pregnant women aged 18-45 years
- Third trimester of pregnancy
- Group A: women diagnosed with preeclampsia according to international criteria (blood pressure ≥ 140/90 mmHg after 20 weeks with proteinuria or signs of severity)
- Group B (controls): normotensive pregnant women without proteinuria or cardiovascular disease
- Signed informed consent
You may not qualify if:
- Known pre-existing cardiovascular disease (structural heart disease, heart failure, chronic hypertension complicated)
- Left ventricular ejection fraction \< 45%
- Pre-gestational diabetes
- Chronic kidney disease
- Multiple pregnancy
- Other severe comorbidities that could affect cardiac function independently of preeclampsia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maternity and Neonatology Center of Tunis
Tunis, 1007, Tunisia
Related Publications (5)
Soma-Pillay P, Louw MC, Adeyemo AO, Makin J, Pattinson RC. Cardiac diastolic function after recovery from pre-eclampsia. Cardiovasc J Afr. 2018 Jan/Feb 23;29(1):26-31. doi: 10.5830/CVJA-2017-031. Epub 2017 Aug 31.
PMID: 28906533RESULTGuirguis GF, Aziz MM, Boccia Liang C, Williams SF, Apuzzio JJ, Bilinski R, Mornan AJ, Shah LP. Is preeclampsia an independent predictor of diastolic dysfunction? A retrospective cohort study. Pregnancy Hypertens. 2015 Oct;5(4):359-61. doi: 10.1016/j.preghy.2015.10.001. Epub 2015 Oct 9.
PMID: 26597754RESULTVaught AJ, Kovell LC, Szymanski LM, Mayer SA, Seifert SM, Vaidya D, Murphy JD, Argani C, O'Kelly A, York S, Ouyang P, Mukherjee M, Zakaria S. Acute Cardiac Effects of Severe Pre-Eclampsia. J Am Coll Cardiol. 2018 Jul 3;72(1):1-11. doi: 10.1016/j.jacc.2018.04.048.
PMID: 29957219RESULTMelchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011 Jan;57(1):85-93. doi: 10.1161/HYPERTENSIONAHA.110.162321. Epub 2010 Nov 22.
PMID: 21098311RESULTNagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011. No abstract available.
PMID: 27037982RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ben marzouk sofiene
Maternity and Neonatology Center of Tunis
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anesthesiology and Critical Care, Principal Investigator
Study Record Dates
First Submitted
September 1, 2025
First Posted
September 24, 2025
Study Start
March 1, 2025
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
September 24, 2025
Record last verified: 2025-09